{
  "paper_metadata": {
    "pmid": "35665499",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses various mutations in the TTR gene associated with transthyretin amyloid polyneuropathy (ATTR-PN), detailing their clinical significance, patient demographics, and penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.89G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 13,
        "demographics": "41 patients with ATTR-PN, mean age 50.3 \u00b1 13.3 years, 30 males and 11 females",
        "phenotype": "transthyretin amyloid polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 41,
        "affected_count": 41,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "transthyretin amyloid polyneuropathy",
          "evidence_sentence": "All patients had TTR gene mutation, with Val30Met in thirteen."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is the most common pathogenic variant overall.",
        "assays": []
      },
      "segregation_data": "The mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met mutation is particularly noted for its high prevalence in ATTR-PN.",
      "key_quotes": [
        "The TTR Val30Met mutation is the most common pathogenic variant overall."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.89G>T",
      "protein_notation": "p.Val30Leu",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 4,
        "demographics": "41 patients with ATTR-PN, mean age 50.3 \u00b1 13.3 years, 30 males and 11 females",
        "phenotype": "transthyretin amyloid polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 41,
        "affected_count": 41,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "transthyretin amyloid polyneuropathy",
          "evidence_sentence": "All patients had TTR gene mutation, with Val30Leu in four."
        }
      ],
      "functional_data": {
        "summary": "The Val30Leu mutation is associated with ATTR-PN.",
        "assays": []
      },
      "segregation_data": "The mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Leu mutation is less common than Val30Met but still significant.",
      "key_quotes": [
        "All patients had TTR gene mutation, with Val30Leu in four."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.290C>T",
      "protein_notation": "p.Ala97Ser",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 3,
        "demographics": "41 patients with ATTR-PN, mean age 50.3 \u00b1 13.3 years, 30 males and 11 females",
        "phenotype": "transthyretin amyloid polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 41,
        "affected_count": 41,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "transthyretin amyloid polyneuropathy",
          "evidence_sentence": "All patients had TTR gene mutation, with Ala97Ser in three."
        }
      ],
      "functional_data": {
        "summary": "The Ala97Ser mutation is associated with ATTR-PN.",
        "assays": []
      },
      "segregation_data": "The mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Ala97Ser mutation is less common than Val30Met and Val30Leu.",
      "key_quotes": [
        "All patients had TTR gene mutation, with Ala97Ser in three."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.104A>C",
      "protein_notation": "p.Lys35Asn",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 3,
        "demographics": "41 patients with ATTR-PN, mean age 50.3 \u00b1 13.3 years, 30 males and 11 females",
        "phenotype": "transthyretin amyloid polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 41,
        "affected_count": 41,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "transthyretin amyloid polyneuropathy",
          "evidence_sentence": "All patients had TTR gene mutation, with Lys35Asn in three."
        }
      ],
      "functional_data": {
        "summary": "The Lys35Asn mutation is associated with ATTR-PN.",
        "assays": []
      },
      "segregation_data": "The mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Lys35Asn mutation is less common than Val30Met and Val30Leu.",
      "key_quotes": [
        "All patients had TTR gene mutation, with Lys35Asn in three."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.107C>G",
      "protein_notation": "p.Ala36Pro",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 2,
        "demographics": "41 patients with ATTR-PN, mean age 50.3 \u00b1 13.3 years, 30 males and 11 females",
        "phenotype": "transthyretin amyloid polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 41,
        "affected_count": 41,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P5",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "transthyretin amyloid polyneuropathy",
          "evidence_sentence": "All patients had TTR gene mutation, with Ala36Pro in two."
        }
      ],
      "functional_data": {
        "summary": "The Ala36Pro mutation is associated with ATTR-PN.",
        "assays": []
      },
      "segregation_data": "The mutation segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Ala36Pro mutation is less common than Val30Met and Val30Leu.",
      "key_quotes": [
        "All patients had TTR gene mutation, with Ala36Pro in two."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 2",
      "table_caption": "Clinical and pathologic findings of subgroups in ATTR-PN.",
      "variants_extracted": 5
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 5,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant variants in the TTR gene were extracted successfully."
  }
}